Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 42 entries
Sorted by: Best Match Show Resources per page
High-peak power nanosecond optical parametric amplifier with periodically poled KTP.

Optics express

Fragemann A, Pasiskevicius V, Karlsson G, Laurell F.
PMID: 19465997
Opt Express. 2003 Jun 02;11(11):1297-302. doi: 10.1364/oe.11.001297.

A two-stage optical parametric amplifier generating 5 ns 208 kW peak power pulses in the spectral region at 1.535 microm in a diffraction-limited beam was realized in a single periodically poled KTP crystal. The maximum small-signal gain for the...

Cite
Fragemann A, Pasiskevicius V, Karlsson G, et al. High-peak power nanosecond optical parametric amplifier with periodically poled KTP. Opt Express. 2003;11(11):1297-302doi: 10.1364/oe.11.001297.
Fragemann, A., Pasiskevicius, V., Karlsson, G., & Laurell, F. (2003). High-peak power nanosecond optical parametric amplifier with periodically poled KTP. Optics express, 11(11), 1297-302. https://doi.org/10.1364/oe.11.001297
Fragemann, A, et al. "High-peak power nanosecond optical parametric amplifier with periodically poled KTP." Optics express vol. 11,11 (2003): 1297-302. doi: https://doi.org/10.1364/oe.11.001297
Fragemann A, Pasiskevicius V, Karlsson G, Laurell F. High-peak power nanosecond optical parametric amplifier with periodically poled KTP. Opt Express. 2003 Jun 02;11(11):1297-302. doi: 10.1364/oe.11.001297. PMID: 19465997.
Copy Download .nbib Format: NLM
[Hypnotics and tranquillisers. Patients' knowledge and attitudes.].

Laeknabladid

Magnusdottir SD, Karlsson G, Thorarinsson S, Sverrisson G, Sigurdsson JA.
PMID: 19679932
Laeknabladid. 1997 Mar;83(3):148-52.

OBJECTIVE: To elicit patients' views and attitudes towards the use of hypnotics and tranquillisers and their knowledge about such drugs and household remedies.MATERIAL AND METHODS: During 1986-1993 a total of 577 individuals in Egilsstaethir district (3029 inhabitants) had used...

Cite
Magnusdottir SD, Karlsson G, Thorarinsson S, et al. [Hypnotics and tranquillisers. Patients' knowledge and attitudes.]. Laeknabladid. 1997;83(3):148-52
Magnusdottir, S. D., Karlsson, G., Thorarinsson, S., Sverrisson, G., & Sigurdsson, J. A. (1997). [Hypnotics and tranquillisers. Patients' knowledge and attitudes.]. Laeknabladid, 83(3), 148-52.
Magnusdottir, S D, et al. "[Hypnotics and tranquillisers. Patients' knowledge and attitudes.]." Laeknabladid vol. 83,3 (1997): 148-52.
Magnusdottir SD, Karlsson G, Thorarinsson S, Sverrisson G, Sigurdsson JA. [Hypnotics and tranquillisers. Patients' knowledge and attitudes.]. Laeknabladid. 1997 Mar;83(3):148-52. Icelandic. PMID: 19679932.
Copy Download .nbib Format: NLM
Diode-Pumped Er-Yb:Glass Laser Passively Q Switched by Use of Co(2+):MgAl(2)O(4) as a Saturable Absorber.

Applied optics

Karlsson G, Pasiskevicius V, Laurell F, Tellefsen JA, Denker B, Galagan BI, Osiko VV, Sverchkov S.
PMID: 18354626
Appl Opt. 2000 Nov 20;39(33):6188-92. doi: 10.1364/ao.39.006188.

We report on passively Q-switched operation of a diode-pumped Er-Yb:glass laser with a Co(2+):MgAl(2)O(4) plate as a saturable absorber. Optical pulses with peak power exceeding 2 kW and a pulse length of 2.3 ns have been generated. Single-longitudinal-mode Q-switched...

Cite
Karlsson G, Pasiskevicius V, Laurell F, et al. Diode-Pumped Er-Yb:Glass Laser Passively Q Switched by Use of Co(2+):MgAl(2)O(4) as a Saturable Absorber. Appl Opt. 2000;39(33):6188-92doi: 10.1364/ao.39.006188.
Karlsson, G., Pasiskevicius, V., Laurell, F., Tellefsen, J. A., Denker, B., Galagan, B. I., Osiko, V. V., & Sverchkov, S. (2000). Diode-Pumped Er-Yb:Glass Laser Passively Q Switched by Use of Co(2+):MgAl(2)O(4) as a Saturable Absorber. Applied optics, 39(33), 6188-92. https://doi.org/10.1364/ao.39.006188
Karlsson, G, et al. "Diode-Pumped Er-Yb:Glass Laser Passively Q Switched by Use of Co(2+):MgAl(2)O(4) as a Saturable Absorber." Applied optics vol. 39,33 (2000): 6188-92. doi: https://doi.org/10.1364/ao.39.006188
Karlsson G, Pasiskevicius V, Laurell F, Tellefsen JA, Denker B, Galagan BI, Osiko VV, Sverchkov S. Diode-Pumped Er-Yb:Glass Laser Passively Q Switched by Use of Co(2+):MgAl(2)O(4) as a Saturable Absorber. Appl Opt. 2000 Nov 20;39(33):6188-92. doi: 10.1364/ao.39.006188. PMID: 18354626.
Copy Download .nbib Format: NLM
Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Papanas N, Elisaf M, Kotsa K, Melidonis A, Bousboulas S, Bargiota A, Pagkalos E, Doupis J, Ioannidis I, Avramidis I, Pappas AC, Karousos G, Arvaniti E, Bristianou M, Pietri K, Karamousouli E, Voss B, Migdalis I, Tentolouris N.
PMID: 33011924
Diabetes Ther. 2020 Dec;11(12):2887-2908. doi: 10.1007/s13300-020-00935-6. Epub 2020 Oct 03.

INTRODUCTION: Physician adherence, or lack therefore, to diabetes care and follow-up guidelines may be linked to the rates of achieving suboptimal glycaemic, blood pressure and lipid targets in people with type 2 diabetes mellitus (T2DM). In this cross-sectional study...

Cite
Papanas N, Elisaf M, Kotsa K, et al. Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study. Diabetes Ther. 2020;11(12):2887-2908doi: 10.1007/s13300-020-00935-6.
Papanas, N., Elisaf, M., Kotsa, K., Melidonis, A., Bousboulas, S., Bargiota, A., Pagkalos, E., Doupis, J., Ioannidis, I., Avramidis, I., Pappas, A. C., Karousos, G., Arvaniti, E., Bristianou, M., Pietri, K., Karamousouli, E., Voss, B., Migdalis, I., & Tentolouris, N. (2020). Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 11(12), 2887-2908. https://doi.org/10.1007/s13300-020-00935-6
Papanas, Nikolaos, et al. "Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 11,12 (2020): 2887-2908. doi: https://doi.org/10.1007/s13300-020-00935-6
Papanas N, Elisaf M, Kotsa K, Melidonis A, Bousboulas S, Bargiota A, Pagkalos E, Doupis J, Ioannidis I, Avramidis I, Pappas AC, Karousos G, Arvaniti E, Bristianou M, Pietri K, Karamousouli E, Voss B, Migdalis I, Tentolouris N. Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study. Diabetes Ther. 2020 Dec;11(12):2887-2908. doi: 10.1007/s13300-020-00935-6. Epub 2020 Oct 03. PMID: 33011924; PMCID: PMC7644661.
Copy Download .nbib Format: NLM
Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals.

Dementia (London, England)

Zeiler K, Karlsson G, Gunnarson M.
PMID: 34380348
Dementia (London). 2022 Jan;21(1):236-249. doi: 10.1177/14713012211035373. Epub 2021 Aug 11.

Since 2017, opportunistic screening for cognitive impairment takes place at the geriatric ward of a local hospital in Sweden. Persons above the age of 65 who are admitted to the ward, who have not been tested for cognitive impairment...

Cite
Zeiler K, Karlsson G, Gunnarson M. Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London). 2021;21(1):236-249doi: 10.1177/14713012211035373.
Zeiler, K., Karlsson, G., & Gunnarson, M. (2022). Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London, England), 21(1), 236-249. https://doi.org/10.1177/14713012211035373
Zeiler, Kristin, et al. "Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals." Dementia (London, England) vol. 21,1 (2022): 236-249. doi: https://doi.org/10.1177/14713012211035373
Zeiler K, Karlsson G, Gunnarson M. Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London). 2022 Jan;21(1):236-249. doi: 10.1177/14713012211035373. Epub 2021 Aug 11. PMID: 34380348.
Copy Download .nbib Format: NLM
A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.

Frontiers in bioscience (Landmark edition)

Petrou P, Kassis I, Yaghmour NE, Ginzberg A, Karussis D.
PMID: 34719198
Front Biosci (Landmark Ed). 2021 Oct 30;26(10):693-706. doi: 10.52586/4980.

No abstract available.

Cite
Petrou P, Kassis I, Yaghmour NE, et al. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front Biosci (Landmark Ed). 2021;26(10):693-706doi: 10.52586/4980.
Petrou, P., Kassis, I., Yaghmour, N. E., Ginzberg, A., & Karussis, D. (2021). A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Frontiers in bioscience (Landmark edition), 26(10), 693-706. https://doi.org/10.52586/4980
Petrou, Panayiota, et al. "A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis." Frontiers in bioscience (Landmark edition) vol. 26,10 (2021): 693-706. doi: https://doi.org/10.52586/4980
Petrou P, Kassis I, Yaghmour NE, Ginzberg A, Karussis D. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front Biosci (Landmark Ed). 2021 Oct 30;26(10):693-706. doi: 10.52586/4980. PMID: 34719198.
Copy Download .nbib Format: NLM
Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs.

Genes, chromosomes & cancer

Pfisterer U, Bräunig J, Brattås P, Heidenblad M, Karlsson G, Fioretos T.
PMID: 33611828
Genes Chromosomes Cancer. 2021 Jul;60(7):504-524. doi: 10.1002/gcc.22944. Epub 2021 Mar 15.

The ability to capture alterations in the genome or transcriptome by next-generation sequencing has provided critical insight into molecular changes and programs underlying cancer biology. With the rapid technological development in single-cell sequencing, it has become possible to study...

Cite
Pfisterer U, Bräunig J, Brattås P, et al. Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs. Genes Chromosomes Cancer. 2021;60(7):504-524doi: 10.1002/gcc.22944.
Pfisterer, U., Bräunig, J., Brattås, P., Heidenblad, M., Karlsson, G., & Fioretos, T. (2021). Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs. Genes, chromosomes & cancer, 60(7), 504-524. https://doi.org/10.1002/gcc.22944
Pfisterer, Ulrich, et al. "Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs." Genes, chromosomes & cancer vol. 60,7 (2021): 504-524. doi: https://doi.org/10.1002/gcc.22944
Pfisterer U, Bräunig J, Brattås P, Heidenblad M, Karlsson G, Fioretos T. Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs. Genes Chromosomes Cancer. 2021 Jul;60(7):504-524. doi: 10.1002/gcc.22944. Epub 2021 Mar 15. PMID: 33611828.
Copy Download .nbib Format: NLM
Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals.

Dementia (London, England)

Zeiler K, Karlsson G, Gunnarson M.
PMID: 34380348
Dementia (London). 2021 Aug 11;14713012211035373. doi: 10.1177/14713012211035373. Epub 2021 Aug 11.

Since 2017, opportunistic screening for cognitive impairment takes place at the geriatric ward of a local hospital in Sweden. Persons above the age of 65 who are admitted to the ward, who have not been tested for cognitive impairment...

Cite
Zeiler K, Karlsson G, Gunnarson M. Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London). 2021;14713012211035373doi: 10.1177/14713012211035373.
Zeiler, K., Karlsson, G., & Gunnarson, M. (2021). Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London, England), 14713012211035373. https://doi.org/10.1177/14713012211035373
Zeiler, Kristin, et al. "Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals." Dementia (London, England) vol. (2021): 14713012211035373. doi: https://doi.org/10.1177/14713012211035373
Zeiler K, Karlsson G, Gunnarson M. Opportunistic cognitive screening in Sweden: What the tests mean and do for patients and healthcare professionals. Dementia (London). 2021 Aug 11;14713012211035373. doi: 10.1177/14713012211035373. Epub 2021 Aug 11. PMID: 34380348.
Copy Download .nbib Format: NLM
Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment.

Placenta

Nathan NO, Hedegaard M, Karlsson G, Knudsen LE, Mathiesen L.
PMID: 34329968
Placenta. 2021 Sep 01;112:105-110. doi: 10.1016/j.placenta.2021.07.289. Epub 2021 Jul 23.

INTRODUCTION: Investigation of the maternal to fetal transfer of oxytocin across the dually perfused term human placenta.METHODS: Human placentae obtained from term singleton pregnancies were utilized in a dual recirculating model of ex vivo placental perfusion. Six placentae from...

Cite
Nathan NO, Hedegaard M, Karlsson G, et al. Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment. Placenta. 2021;112:105-110doi: 10.1016/j.placenta.2021.07.289.
Nathan, N. O., Hedegaard, M., Karlsson, G., Knudsen, L. E., & Mathiesen, L. (2021). Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment. Placenta, 112105-110. https://doi.org/10.1016/j.placenta.2021.07.289
Nathan, Nina Olsén, et al. "Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment." Placenta vol. 112 (2021): 105-110. doi: https://doi.org/10.1016/j.placenta.2021.07.289
Nathan NO, Hedegaard M, Karlsson G, Knudsen LE, Mathiesen L. Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment. Placenta. 2021 Sep 01;112:105-110. doi: 10.1016/j.placenta.2021.07.289. Epub 2021 Jul 23. PMID: 34329968.
Copy Download .nbib Format: NLM
Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels.

Blood

Lopez de Lapuente Portilla A, Ekdahl L, Cafaro C, Ali Z, Miharada N, Thorleifsson G, Žemaitis K, Lamarca Arrizabalaga A, Thodberg M, Pertesi M, Dhapola P, Bao EL, Niroula A, Bali D, Norddahl GL, Ugidos Damboriena N, Sankaran VG, Karlsson G, Thorsteinsdottir U, Larsson J, Stefansson K, Nilsson B.
PMID: 35007327
Blood. 2022 Jan 10; doi: 10.1182/blood.2021013220. Epub 2022 Jan 10.

Stem cell transplantation is a cornerstone in the treatment of blood malignancies. The most common method to harvest stem cells for transplantation is by leukapheresis, requiring mobilization of CD34+ hematopoietic stem and progenitor cells (HSPC) from the bone marrow...

Cite
Lopez de Lapuente Portilla A, Ekdahl L, Cafaro C, et al. Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels. Blood. 2022;doi: 10.1182/blood.2021013220.
Lopez de Lapuente Portilla, A., Ekdahl, L., Cafaro, C., Ali, Z., Miharada, N., Thorleifsson, G., Žemaitis, K., Lamarca Arrizabalaga, A., Thodberg, M., Pertesi, M., Dhapola, P., Bao, E. L., Niroula, A., Bali, D., Norddahl, G. L., Ugidos Damboriena, N., Sankaran, V. G., Karlsson, G., Thorsteinsdottir, U., Larsson, J., Stefansson, K., & Nilsson, B. (2022). Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels. Blood, . https://doi.org/10.1182/blood.2021013220
Lopez de Lapuente Portilla, Aitzkoa, et al. "Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels." Blood vol. (2022). doi: https://doi.org/10.1182/blood.2021013220
Lopez de Lapuente Portilla A, Ekdahl L, Cafaro C, Ali Z, Miharada N, Thorleifsson G, Žemaitis K, Lamarca Arrizabalaga A, Thodberg M, Pertesi M, Dhapola P, Bao EL, Niroula A, Bali D, Norddahl GL, Ugidos Damboriena N, Sankaran VG, Karlsson G, Thorsteinsdottir U, Larsson J, Stefansson K, Nilsson B. Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels. Blood. 2022 Jan 10; doi: 10.1182/blood.2021013220. Epub 2022 Jan 10. PMID: 35007327.
Copy Download .nbib Format: NLM
How rare and common risk variation jointly affect liability for autism spectrum disorder.

Molecular autism

Klei L, McClain LL, Mahjani B, Panayidou K, De Rubeis S, Grahnat AS, Karlsson G, Lu Y, Melhem N, Xu X, Reichenberg A, Sandin S, Hultman CM, Buxbaum JD, Roeder K, Devlin B.
PMID: 34615521
Mol Autism. 2021 Oct 06;12(1):66. doi: 10.1186/s13229-021-00466-2.

BACKGROUND: Genetic studies have implicated rare and common variations in liability for autism spectrum disorder (ASD). Of the discovered risk variants, those rare in the population invariably have large impact on liability, while common variants have small effects. Yet,...

Cite
Klei L, McClain LL, Mahjani B, et al. How rare and common risk variation jointly affect liability for autism spectrum disorder. Mol Autism. 2021;12(1):66doi: 10.1186/s13229-021-00466-2.
Klei, L., McClain, L. L., Mahjani, B., Panayidou, K., De Rubeis, S., Grahnat, A. S., Karlsson, G., Lu, Y., Melhem, N., Xu, X., Reichenberg, A., Sandin, S., Hultman, C. M., Buxbaum, J. D., Roeder, K., & Devlin, B. (2021). How rare and common risk variation jointly affect liability for autism spectrum disorder. Molecular autism, 12(1), 66. https://doi.org/10.1186/s13229-021-00466-2
Klei, Lambertus, et al. "How rare and common risk variation jointly affect liability for autism spectrum disorder." Molecular autism vol. 12,1 (2021): 66. doi: https://doi.org/10.1186/s13229-021-00466-2
Klei L, McClain LL, Mahjani B, Panayidou K, De Rubeis S, Grahnat AS, Karlsson G, Lu Y, Melhem N, Xu X, Reichenberg A, Sandin S, Hultman CM, Buxbaum JD, Roeder K, Devlin B. How rare and common risk variation jointly affect liability for autism spectrum disorder. Mol Autism. 2021 Oct 06;12(1):66. doi: 10.1186/s13229-021-00466-2. PMID: 34615521; PMCID: PMC8495987.
Copy Download .nbib Format: NLM
A new view on chemistry of solids in solution--cryo energy-filtered transmission electron microscopy (cryo-EFTEM) imaging of aggregating palladium colloids in vitreous ice.

Chemistry (Weinheim an der Bergstrasse, Germany)

Bovin JO, Huber T, Balmes O, Malm JO, Karlsson G.
PMID: 10747396
Chemistry. 2000 Jan;6(1):129-32. doi: 10.1002/(sici)1521-3765(20000103)6:1<129::aid-chem129>3.0.co;2-y.

It is shown that by using cryo-transmission electron microscopy (cryo-TEM) it is possible to image the aggregation behaviour of nanoparticles while they are still in solution. This technique has allowed the study of the arrangement of colloidal palladium particles...

Cite
Bovin JO, Huber T, Balmes O, et al. A new view on chemistry of solids in solution--cryo energy-filtered transmission electron microscopy (cryo-EFTEM) imaging of aggregating palladium colloids in vitreous ice. Chemistry. 2000;6(1):129-32doi: 10.1002/(sici)1521-3765(20000103)6:1<129::aid-chem129>3.0.co;2-y.
Bovin, J. O., Huber, T., Balmes, O., Malm, J. O., & Karlsson, G. (2000). A new view on chemistry of solids in solution--cryo energy-filtered transmission electron microscopy (cryo-EFTEM) imaging of aggregating palladium colloids in vitreous ice. Chemistry (Weinheim an der Bergstrasse, Germany), 6(1), 129-32. https://doi.org/10.1002/(sici)1521-3765(20000103)6:1<129::aid-chem129>3.0.co;2-y
Bovin, et al. "A new view on chemistry of solids in solution--cryo energy-filtered transmission electron microscopy (cryo-EFTEM) imaging of aggregating palladium colloids in vitreous ice." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 6,1 (2000): 129-32. doi: https://doi.org/10.1002/(sici)1521-3765(20000103)6:1<129::aid-chem129>3.0.co;2-y
Bovin JO, Huber T, Balmes O, Malm JO, Karlsson G. A new view on chemistry of solids in solution--cryo energy-filtered transmission electron microscopy (cryo-EFTEM) imaging of aggregating palladium colloids in vitreous ice. Chemistry. 2000 Jan;6(1):129-32. doi: 10.1002/(sici)1521-3765(20000103)6:1<129::aid-chem129>3.0.co;2-y. PMID: 10747396.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 42 entries